Frontiers in Cell and Developmental Biology,
Journal Year:
2023,
Volume and Issue:
10
Published: Jan. 9, 2023
Plasma
membrane
ionic
channels
selectively
permeate
potassium,
sodium,
calcium,
and
chloride
ions.
However,
large-pore
are
permeable
to
ions
small
molecules
such
as
ATP
glutamate,
among
others.
Large-pore
structures
formed
by
several
protein
families
with
little
or
no
evolutionary
linkages
including
connexins
(Cxs),
pannexins
(Panxs),
innexin
(Inxs),
unnexins
(Unxs),
calcium
homeostasis
modulator
(CALHMs),
Leucine-rich
repeat-containing
8
(LRRC8)
proteins.
key
players
in
inflammatory
cell
response,
guiding
the
activation
of
inflammasomes,
release
pro-inflammatory
cytokines
interleukin-1
beta
(IL-1ß),
adenosine-5'-triphosphate
(ATP),
which
is
considered
a
danger
signal.
This
review
summarizes
our
current
understanding
their
contribution
inflammation
induced
microorganisms,
virulence
factors
toxins.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(3)
Published: Jan. 17, 2025
Viruses
engage
in
a
variety
of
processes
to
subvert
host
defenses
and
create
an
environment
amenable
replication.
Here,
using
rotavirus
as
prototype,
we
show
that
calcium
conductance
out
the
endoplasmic
reticulum
by
virus
encoded
ion
channel,
NSP4,
induces
intercellular
waves
extend
beyond
infected
cell
contribute
pathogenesis.
lack
ability
induce
this
signaling
diminished
viral
shedding
attenuated
disease
mouse
model
diarrhea.
This
implicates
nonstructural
protein
4
(NSP4)
virulence
factor
provides
mechanistic
insight
into
its
mode
action.
Critically,
transcriptional
signature
characteristic
interferon-independent
innate
immune
activation,
which
is
not
observed
response
mutant
NSP4
does
conduct
calcium.
dysregulation
means
pathogen
recognition,
theme
broadly
applicable
calcium-altering
pathogens
rotavirus.
Cells,
Journal Year:
2022,
Volume and Issue:
11(15), P. 2379 - 2379
Published: Aug. 2, 2022
The
major
barrier
to
cure
HIV
infection
is
the
early
generation
and
extended
survival
of
reservoirs
in
circulation
tissues.
Currently,
techniques
used
detect
quantify
are
mostly
based
on
blood-based
assays;
however,
it
has
become
evident
that
viral
remain
Our
study
describes
a
novel
multi-component
imaging
method
(HIV
DNA,
mRNA,
proteins
same
assay)
identify,
quantify,
characterize
tissues
blood
products
obtained
from
HIV-infected
individuals
even
when
systemic
replication
undetectable.
In
human
brains
under
ART,
we
identified
microglia/macrophages
small
population
astrocytes
main
cells
with
integrated
DNA.
Only
half
DNA
expressed
one-third
proteins.
Surprisingly,
residual
HIV-p24,
gp120,
nef,
vpr,
tat
protein
expression
accumulation
uninfected
around
suggesting
local
synthesis,
secretion,
bystander
uptake.
conclusion,
our
data
show
ART
reduces
size
brain’s
reservoirs;
local/chronic
secretion
still
occurs,
indicating
brain
anatomical
target
infection.
Biology,
Journal Year:
2022,
Volume and Issue:
11(2), P. 237 - 237
Published: Feb. 2, 2022
The
connexin
protein
family
consists
of
approximately
20
members,
and
is
well
recognized
as
the
structural
unit
gap
junction
channels
that
perforate
plasma
membranes
coupled
cells
and,
thereby,
mediate
intercellular
communication.
Gap
junctions
are
assembled
by
two
preexisting
hemichannels
on
apposing
cells.
Non-junctional
(CxHC)
provide
a
conduit
between
cell
interior
extracellular
milieu,
believed
to
be
in
protectively
closed
state
under
physiological
conditions.
development
characterization
peptide
mimetics
amino
acid
sequences
connexins
have
resulted
panel
blockers
with
higher
selectivity
for
CxHC,
which
become
important
tools
defining
role
CxHC
various
biological
processes.
It
increasingly
clear
can
induced
open
pathogen-associated
molecular
patterns.
opening
facilitates
release
damage-associated
patterns,
class
endogenous
molecules
critical
pathogenesis
inflammatory
diseases.
blockade
leads
attenuated
inflammation,
reduced
tissue
injury
improved
organ
function
human
animal
models
about
thirty
diseases
disorders.
These
findings
demonstrate
may
contribute
intensification
serve
common
target
treatments
In
this
review,
we
an
update
progress
understanding
focus
these
iScience,
Journal Year:
2024,
Volume and Issue:
27(3), P. 109236 - 109236
Published: Feb. 15, 2024
HIV-associated
neurological
compromise
is
observed
in
more
than
half
of
all
people
with
HIV
(PWH),
even
under
antiretroviral
therapy
(ART).
The
mechanism
has
been
associated
the
early
transmigration
HIV-infected
monocytes
across
BBB
a
CCL2
and
replication-dependent
manner.
However,
mechanisms
chronic
brain
damage
are
unknown.
We
demonstrate
that
PWH
ART
have
elevated
circulating
ATP
levels
correlate
onset
cognitive
impairment
absence
virus.
Serum
found
most
severe
neurocognitive
trigger
transcellular
migration
leukocytes
JAM-A
LFA-1-dependent
propose
targeting
leukocyte
could
reduce
or
prevent
devastating
consequences
within
brains
ART.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
14
Published: Feb. 19, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
triggered
an
unprecedented
concentration
of
economic
and
research
efforts
to
generate
knowledge
at
unequalled
speed
on
deregulated
interferon
type
I
signalling
nuclear
factor
kappa
light
chain
enhancer
in
B-cells
(NF-κB)-driven
interleukin
(IL)-1β,
IL-6,
IL-18
secretion
causing
cytokine
storms.
translation
the
how
resulting
systemic
inflammation
can
lead
life-threatening
complications
into
novel
treatments
vaccine
technologies
is
underway.
Nevertheless,
previously
existing
role
cytoplasmatic
or
circulating
self-DNA
as
a
pro-inflammatory
damage-associated
molecular
pattern
(DAMP)
was
largely
ignored.
Pathologies
reported
‘
de
novo
’
for
patients
infected
with
Severe
Acute
Respiratory
Syndrome
Coronavirus
(SARS-CoV)-2
be
outcomes
self-DNA-driven
fact
had
been
linked
earlier
different
contexts,
e.g.,
infection
Human
Immunodeficiency
Virus
(HIV)-1,
sterile
inflammation,
autoimmune
diseases.
highlight
particularly
synergies
other
DAMPs
render
immunogenic
properties
normally
non-immunogenic
extracellular
self-DNA,
discuss
shared
features
gp41
unit
HIV-1
envelope
protein
SARS-CoV
2
Spike
that
enable
SARS-CoV-2
interact
cell
membranes,
trigger
syncytia
formation,
inflict
damage
their
host’s
DNA,
–
likely
own
benefit.
These
similarities
motivate
speculations
similar
mechanisms
those
driven
by
explain
inflammatory
contributes
some
most
frequent
adverse
events
after
vaccination
BNT162b2
mRNA
(Pfizer/BioNTech)
mRNA-1273
(Moderna)
vaccine,
i.e.,
myocarditis,
herpes
zoster,
rheumatoid
arthritis,
nephritis
hepatitis,
new-onset
lupus
erythematosus,
flare-ups
psoriasis
lupus.
hope
wider
application
lessons
learned
from
experiences
COVID-19
new
vaccines
combat
future
non-COVID-19
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 30, 2025
The
clinical
consequences
of
the
co-infection
with
novel
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
and
syncytial
virus
(RSV)
are
not
optimistic.
Nevertheless,
there
is
currently
no
approved
therapeutic
regimen
specifically
targeting
SARS-CoV-2/RSV
co-infection,
existing
monotherapies
showing
limited
efficacy.
According
to
recent
studies,
probenecid
has
both
anti-SARS-CoV-2
anti-RSV
effects.
Therefore,
as
one
probable
molecular
candidate
for
SARS-CoV-2
RSV,
was
researched
in
this
exploration.
Using
systems
pharmacology
bioinformatics,
we
characterized
targets
associated
treatment
focusing
on
their
biological
functions,
mechanisms
binding
activities.
To
further
validate
these
findings,
conducted
docking,
MD
simulations,
electrostatic
potential
mapping,
SAR
analysis
explore
interactions
between
identified
core
targets.
We
141
that
overlapped
probenecid,
used
shared
construct
a
protein-protein
interaction
(PPI)
network.
Subsequently,
obtained
top
16
hub
namely,
AKT1,
ALB,
EGFR,
CASP3,
CTNNB1,
SRC,
HSP90AA1,
so
on.
enrichment
analysis,
might
affect
inflammation,
immunity,
oxidative
stress,
defenses;
Toll-like
receptor,
TNF,
IL-17,
NOD-like
cytokine-cytokine
among
others.
Additionally,
based
docking
effectively
bound
related
co-infection.
Meanwhile,
according
dynamics
(MD)
simulations
structure-activity
relationship
(SAR)
speculated
SRC
HSP90AA1
more
likely
be
target
proteins
than
other
proteins.
Our
findings
from
bioinformatics
indicate
immune
inflammatory
responses
play
pivotal
role
effects
probenecid.
Infectious
disease-related
pathways
also
contribute
significantly
its
effectiveness
treating
Further
validation
through
analysis.
These
analyses
suggest
This
study
provides
valuable
preliminary
insights
into
It
establishes
strong
foundation
future
research
strategy
Viruses,
Journal Year:
2022,
Volume and Issue:
14(3), P. 612 - 612
Published: March 15, 2022
Viral
replication
and
transmissibility
are
the
principal
causes
of
endemic
pandemic
disease
threats.
There
remains
a
need
for
broad-spectrum
antiviral
agents.
The
most
common
respiratory
viruses
agents
such
as
coronaviruses,
syncytial
viruses,
influenza
viruses.
Although
vaccines
available
SARS-CoV-2
some
there
is
paucity
effective
drugs,
while
RSV
no
vaccine
available,
therapeutic
treatments
very
limited.
We
have
previously
shown
that
probenecid
safe
in
limiting
A
virus
replication,
along
with
strong
evidence
showing
inhibition
vitro
vivo.
This
review
article
will
describe
activity
profile
against
these
three
British Journal of Pharmacology,
Journal Year:
2022,
Volume and Issue:
180(6), P. 685 - 700
Published: Dec. 9, 2022
The
available
pharmacological
options
in
the
management
of
cardiovascular
diseases
such
as
ischaemic
heart
disease
and
subsequent
failure
are
effective
slowing
progression
this
condition.
However,
long‐term
prognosis
is
still
poor,
raising
demand
for
new
therapeutic
strategies.
Drug
repurposing
a
time‐
cost‐effective
drug
development
strategy
that
offers
approved
abandoned
drugs
chance
indications.
Recently,
used
gout‐related
inflammation
canakinumab
or
colchicine
have
been
considered
old
uricosuric
drug,
probenecid,
has
identified
novel
option
specific
cardiac
well.
Probenecid
can
modulate
myocardial
contractility
vascular
tone
exerts
anti‐inflammatory
properties.
mechanisms
behind
these
beneficial
effects
might
be
related
inhibition
inflammasomes,
to
modulation
purinergic–pannexin‐1
signalling
TRPV2
channels,
which
recently
molecular
targets
probenecid.
In
review,
we
provide
an
overview
on
probenecid
by
summarizing
experimental
clinical
data
propose
its
potential
treat
diseases.